These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 12416892)
1. Lymphocyte predominant Hodgkin's disease: more patience than patients. Ekstrand BC; Horning SJ Cancer J; 2002; 8(5):367-8. PubMed ID: 12416892 [No Abstract] [Full Text] [Related]
2. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266 [TBL] [Abstract][Full Text] [Related]
3. Reticuloendothelial system phagocytic function in patients with Hodgkin's disease. Sheagren JN; Block JB; Wolff SM J Clin Invest; 1967 May; 46(5):855-62. PubMed ID: 5337858 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy alone for lymphocyte-predominant Hodgkin's disease. Schlembach PJ; Wilder RB; Jones D; Ha CS; Fayad LE; Younes A; Hagemeister F; Hess M; Cabanillas F; Cox JD Cancer J; 2002; 8(5):377-83. PubMed ID: 12416895 [TBL] [Abstract][Full Text] [Related]
6. [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. Denz H; Lechleitner M; Peschel C; Peer L; Huber H Wien Klin Wochenschr; 1983 May; 95(10):326-32. PubMed ID: 6688488 [TBL] [Abstract][Full Text] [Related]
8. Blood volume studies in patients with Hodgkin's disease. Marczyńska A; Glińska H; Adamczyk B; Pawlicki M Radiobiol Radiother (Berl); 1971; 12(1):63-70. PubMed ID: 5099415 [No Abstract] [Full Text] [Related]
9. [The course of Hodgkin's disease]. Brichta G Wien Z Inn Med; 1972; 53(8):419-26. PubMed ID: 4628841 [No Abstract] [Full Text] [Related]
10. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679 [TBL] [Abstract][Full Text] [Related]
11. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Lishner M; Zemlickis D; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G Br J Cancer; 1992 Jan; 65(1):114-7. PubMed ID: 1733434 [TBL] [Abstract][Full Text] [Related]
12. Subdiaphragmatic Hodgkin's disease: the University of Florida experience. Hull MC; Mendenhall NP; Colgan ME Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634 [TBL] [Abstract][Full Text] [Related]
13. The pulmonary effect of mantle irradiation in patients with Hodgkin's disease. Lokich JJ; Bass H; Eberly FE; Rosenthal DS; Moloney WC Radiology; 1973 Aug; 108(2):397-402. PubMed ID: 4719044 [No Abstract] [Full Text] [Related]
14. Clinical versus pathologic stage I and II Hodgkin's disease. Cox JD; Stoffel TJ Oncology; 1980; 37(5):325-8. PubMed ID: 7443165 [TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease and hypothermia: case report and review of the literature. Robin V; Lebacq J; Michaux L; Ferrant A Ann Hematol; 2002 Feb; 81(2):106-7. PubMed ID: 11907792 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes. Crennan E; D'Costa I; Liew KH; Thompson J; Laidlaw C; Cooper I; Quong G Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):333-7. PubMed ID: 7530700 [TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphomas following radiation therapy alone for Hodgkin's disease. Trenkner DA; Brownell M; Wasserman TH Radiother Oncol; 1986 Jul; 6(3):199-206. PubMed ID: 3749524 [TBL] [Abstract][Full Text] [Related]
18. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. Regula DP; Hoppe RT; Weiss LM N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy. Kirkove C; Timothy AR Hematol Oncol; 1991; 9(3):163-7. PubMed ID: 1937407 [TBL] [Abstract][Full Text] [Related]
20. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Stein H; Hansmann ML; Lennert K; Brandtzaeg P; Gatter KC; Mason DY Am J Clin Pathol; 1986 Sep; 86(3):292-7. PubMed ID: 3529924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]